Takeda Pharmaceutical Company Limited 13F holders
Of the 44 funds followed here, 7 reported a position in Takeda Pharmaceutical Company Limited in a 13F for the quarter ended 30 June 2026. The largest: Capital Research Global Investors, 19.3 million shares worth $309.3 million, 0.0% of its reported book. New this quarter: Millennium Management, Point72 Asset Management.
| Fund | Shares | Value | Of its book | Change on the quarter | Status | Quarter ended | Filing |
|---|---|---|---|---|---|---|---|
| Capital Research Global Investors | 19,297,680 | $309.3 million | 0.0% | +193,461 | added | 30 June 2026 | 13F |
| FMR LLC | 9,599,302 | $153.9 million | 0.0% | +2,481,816 | added | 30 June 2026 | 13F |
| Renaissance Technologies | 2,568,000 | $41.2 million | 0.1% | -421,100 | trimmed | 30 June 2026 | 13F |
| Millennium Management | 1,050,698 | $16.8 million | 0.0% | +1,050,698 | new | 30 June 2026 | 13F |
| Citadel Advisors | 927,028 | $14.9 million | 0.0% | -1,239,432 | trimmed | 30 June 2026 | 13F |
| Two Sigma Investments | 485,733 | $7.8 million | 0.0% | +174,033 | added | 30 June 2026 | 13F |
| Point72 Asset Management | 77,658 | $1.2 million | 0.0% | +77,658 | new | 30 June 2026 | 13F |
Value is what the fund reported. Change is shares against the fund's previous 13F; a fund with one filing read shows no change. 13Fs cover long US positions of managers above $100 million and are filed up to 45 days after the quarter.
Schedule 13D and 13G filed on the name, last twelve months
None in the last twelve months: no holder crossed 5%, changed materially, or filed an annual 13G in the window.
Fails to deliver
| Settlement date | Shares failed | Price | File |
|---|---|---|---|
| 25 August 2026 | 7 | $18.24 | SEC |
| 29 July 2026 | 11,086 | $17.52 | SEC |
| 21 July 2026 | 80 | $17.05 | SEC |
| 20 July 2026 | 879 | $17.15 | SEC |
Shares that failed to deliver at settlement, per day, from the SEC's half-month files, which arrive about two weeks after the period. Largest in the window: 11,086 on 29 July 2026. A fail is an operational fact about settlement, not a position.
Source
Each fund's 13F-HR on EDGAR, linked per row; positions matched to TAK by CUSIP from the SEC's own fails-to-deliver files; Schedule 13D and 13G from the company's own filing index, each read to confirm the company is the issuer named.
The same record on your computer
GreekSoup is also a free program for your own computer. It reads these same filings for the names you follow, refreshed as they land, with no account. One pasted line installs it.